Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 120.38
PDEX's Cash to Debt is ranked higher than
81% of the 309 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.81 vs. PDEX: 120.38 )
PDEX' s 10-Year Cash to Debt Range
Min: 0.01   Max: No Debt
Current: 120.38

Equity to Asset 0.75
PDEX's Equity to Asset is ranked higher than
82% of the 298 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. PDEX: 0.75 )
PDEX' s 10-Year Equity to Asset Range
Min: 0.24   Max: 0.9
Current: 0.75

0.24
0.9
F-Score: 4
Z-Score: 1.90
M-Score: -2.57
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -15.47
PDEX's Operating margin (%) is ranked higher than
57% of the 294 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 10.30 vs. PDEX: -15.47 )
PDEX' s 10-Year Operating margin (%) Range
Min: -55.9   Max: 16.57
Current: -15.47

-55.9
16.57
Net-margin (%) -14.56
PDEX's Net-margin (%) is ranked higher than
59% of the 294 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.98 vs. PDEX: -14.56 )
PDEX' s 10-Year Net-margin (%) Range
Min: -48.71   Max: 19.18
Current: -14.56

-48.71
19.18
ROE (%) -22.48
PDEX's ROE (%) is ranked higher than
57% of the 291 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.68 vs. PDEX: -22.48 )
PDEX' s 10-Year ROE (%) Range
Min: -211.41   Max: 32.18
Current: -22.48

-211.41
32.18
ROA (%) -16.84
PDEX's ROA (%) is ranked higher than
57% of the 299 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.50 vs. PDEX: -16.84 )
PDEX' s 10-Year ROA (%) Range
Min: -50.48   Max: 24.24
Current: -16.84

-50.48
24.24
ROC (Joel Greenblatt) (%) -34.94
PDEX's ROC (Joel Greenblatt) (%) is ranked higher than
59% of the 297 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.48 vs. PDEX: -34.94 )
PDEX' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -133.57   Max: 45.38
Current: -34.94

-133.57
45.38
Revenue Growth (%) -19.90
PDEX's Revenue Growth (%) is ranked higher than
53% of the 276 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.70 vs. PDEX: -19.90 )
PDEX' s 10-Year Revenue Growth (%) Range
Min: -23.6   Max: 20.9
Current: -19.9

-23.6
20.9
EBITDA Growth (%) -19.90
PDEX's EBITDA Growth (%) is ranked higher than
53% of the 238 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.40 vs. PDEX: -19.90 )
PDEX' s 10-Year EBITDA Growth (%) Range
Min: -47.4   Max: 57
Current: -19.9

-47.4
57
EPS Growth (%) -15.30
PDEX's EPS Growth (%) is ranked higher than
59% of the 242 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.20 vs. PDEX: -15.30 )
PDEX' s 10-Year EPS Growth (%) Range
Min: -49.7   Max: 104.1
Current: -15.3

-49.7
104.1
» PDEX's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with PDEX

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 0.90
PDEX's P/B is ranked higher than
96% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.25 vs. PDEX: 0.90 )
PDEX' s 10-Year P/B Range
Min: 0.26   Max: 3.69
Current: 0.9

0.26
3.69
P/S 0.70
PDEX's P/S is ranked higher than
95% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.80 vs. PDEX: 0.70 )
PDEX' s 10-Year P/S Range
Min: 0.15   Max: 2.51
Current: 0.7

0.15
2.51
EV-to-EBIT -4.42
PDEX's EV-to-EBIT is ranked higher than
57% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.48 vs. PDEX: -4.42 )
PDEX' s 10-Year EV-to-EBIT Range
Min: 0.5   Max: 48.6
Current: -4.42

0.5
48.6
Current Ratio 3.42
PDEX's Current Ratio is ranked higher than
81% of the 244 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.89 vs. PDEX: 3.42 )
PDEX' s 10-Year Current Ratio Range
Min: 0.7   Max: 7.5
Current: 3.42

0.7
7.5
Quick Ratio 1.98
PDEX's Quick Ratio is ranked higher than
74% of the 244 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.84 vs. PDEX: 1.98 )
PDEX' s 10-Year Quick Ratio Range
Min: 0.33   Max: 5
Current: 1.98

0.33
5

Valuation & Return

vs
industry
vs
history
Price/Net Current Asset Value 2.60
PDEX's Price/Net Current Asset Value is ranked higher than
96% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. PDEX: 2.60 )
PDEX' s 10-Year Price/Net Current Asset Value Range
Min: 1.52   Max: 483
Current: 2.6

1.52
483
Price/Tangible Book 0.90
PDEX's Price/Tangible Book is ranked higher than
97% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.39 vs. PDEX: 0.90 )
PDEX' s 10-Year Price/Tangible Book Range
Min: 0.46   Max: 16.13
Current: 0.9

0.46
16.13
Price/DCF (Projected) 0.60
PDEX's Price/DCF (Projected) is ranked higher than
98% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.22 vs. PDEX: 0.60 )
PDEX' s 10-Year Price/DCF (Projected) Range
Min: 0.33   Max: 5.93
Current: 0.6

0.33
5.93
Price/Median PS Value 1.10
PDEX's Price/Median PS Value is ranked higher than
74% of the 322 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.14 vs. PDEX: 1.10 )
PDEX' s 10-Year Price/Median PS Value Range
Min: 0.3   Max: 4.8
Current: 1.1

0.3
4.8
Earnings Yield (Greenblatt) 20.00
PDEX's Earnings Yield (Greenblatt) is ranked higher than
94% of the 262 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.40 vs. PDEX: 20.00 )
PDEX' s 10-Year Earnings Yield (Greenblatt) Range
Min: 2.1   Max: 189
Current: 20

2.1
189
Forward Rate of Return (Yacktman) 13.89
PDEX's Forward Rate of Return (Yacktman) is ranked higher than
87% of the 260 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.14 vs. PDEX: 13.89 )
PDEX' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -4.7   Max: 23.6
Current: 13.89

-4.7
23.6

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Pro-Dex, Inc., was incorporated in the State of Colorado. The Company with operations in Irvine, California and Beaverton, Oregon, designs and produces powered surgical and dental instruments and motion control products used in the medical, factory automation and scientific research industries. The Company's products are found in hospitals, dental offices, medical engineering labs, commercial and military aircraft, scientific research facilities and high-tech manufacturing operations around the world. The names Micro Motors, Oregon Micro Systems, and Astromec are used for marketing purposes as brand names. The majority of its revenue is derived from designing, developing and manufacturing powered instruments for the medical and dental industries, and motion control software and hardware for industrial and scientific applications. The Company's medical device products utilize proprietary designs developed by it under exclusive design and supply agreements and are manufactured in its Irvine, California facility, as are its dental products. Its medical device products are sold mainly to original equipment manufacturers and its dental products are sold mainly to dental product distributors. In its Beaverton, Oregon facility, it design and manufacture embedded multi-axis motion controllers which are sold to distributors or original equipment manufacturers in the automation or research industries. The Company competes in all of its markets with other major medical device and motion control related companies. As a provider of outsourced services, it also competes with its customers' own internal development and manufacturing groups. The manufacture and distribution of medical and dental devices are subject to state and federal requirements set forth by various agencies including state dental boards and the U.S. Food and Drug Administration.
» More Articles for PDEX

Headlines

Articles On GuruFocus.com
Incentives matter: Pro-Dex (PDEX) Oct 10 2013 
BSX and ABMD Highlight Increased Insider Buying in the Medical Technology Sector May 14 2013 
Pro-Dex Inc: Are Stories Of Its Death Greatly Exaggerated? Dec 12 2011 
ProDex Inc. Reports Operating Results (10-Q) Feb 10 2011 
ProDex Inc. (PDEX) CEO Mark Phillip Murphy buys 23,946 Shares Nov 06 2009 
ProDex Inc. (PDEX) CEO Mark Phillip Murphy buys 15,000 Shares Nov 04 2009 
ProDex Inc. Reports Operating Results (10-K) Sep 17 2009 
ProDex Inc. (PDEX) CEO Mark Phillip Murphy buys 28,000 Shares Jun 11 2009 
ProDex Inc. (PDEX) CEO Mark Phillip Murphy buys 19,504 Shares Jun 04 2009 
ProDex Inc. (pdex) CEO Mark Phillip Murphy buys 6,679 Shares May 29 2009 

More From Other Websites
PRO DEX INC Files SEC form 8-K/A, Entry into a Material Definitive Agreement Jul 10 2014
PRO DEX INC Files SEC form 8-K, Entry into a Material Definitive Agreement Jul 09 2014
Pro-Dex Shares Now Offer Investors The Same Turnaround Story As Before At A Greatly Reduced... Jun 27 2014
PRO DEX INC Financials May 21 2014
Pro-Dex's (PDEX) CEO Hal Hurwitz on F3Q 2014 Results - Earnings Call Transcript May 12 2014
PRO DEX INC Files SEC form 8-K, Results of Operations and Financial Condition May 12 2014
PRO DEX INC Files SEC form 10-Q, Quarterly Report May 12 2014
Pro-Dex, Inc. Announces Fiscal 2014 Third Quarter and Nine-Month Results May 12 2014
Pro-Dex, Inc. Announces Fiscal 2014 Third Quarter Financial Results Conference Call And Webcast May 06 2014
PRO DEX INC Files SEC form 8-K, Other Events May 01 2014
Pro-Dex, Inc. Announces Completion Of Rights Offering May 01 2014
Pro-Dex, Inc. Announces Commencement Of Rights Offering Mar 24 2014
PRO DEX INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Mar 24 2014
Pro-Dex, Inc. Announces Commencement Of Rights Offering Mar 24 2014
PRO DEX INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Mar 10 2014
PRO-DEX, INC. Announces Record Date For Planned Rights Offering Mar 10 2014
Pro-Dex's CEO Discusses F2Q 2014 Results - Earnings Call Transcript Feb 07 2014
Pro-Dex, Inc. Announces Fiscal 2014 Second Quarter Results Feb 07 2014
PRO DEX INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Feb 06 2014
PRO DEX INC Files SEC form 10-Q, Quarterly Report Feb 06 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK